Correlation Between Acumen Pharmaceuticals and SSMTF
Can any of the company-specific risk be diversified away by investing in both Acumen Pharmaceuticals and SSMTF at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acumen Pharmaceuticals and SSMTF into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acumen Pharmaceuticals and SSMTF, you can compare the effects of market volatilities on Acumen Pharmaceuticals and SSMTF and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acumen Pharmaceuticals with a short position of SSMTF. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acumen Pharmaceuticals and SSMTF.
Diversification Opportunities for Acumen Pharmaceuticals and SSMTF
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Acumen and SSMTF is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Acumen Pharmaceuticals and SSMTF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on SSMTF and Acumen Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acumen Pharmaceuticals are associated (or correlated) with SSMTF. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of SSMTF has no effect on the direction of Acumen Pharmaceuticals i.e., Acumen Pharmaceuticals and SSMTF go up and down completely randomly.
Pair Corralation between Acumen Pharmaceuticals and SSMTF
If you would invest 0.15 in SSMTF on October 8, 2024 and sell it today you would earn a total of 0.00 from holding SSMTF or generate 0.0% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 4.02% |
Values | Daily Returns |
Acumen Pharmaceuticals vs. SSMTF
Performance |
Timeline |
Acumen Pharmaceuticals |
SSMTF |
Acumen Pharmaceuticals and SSMTF Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Acumen Pharmaceuticals and SSMTF
The main advantage of trading using opposite Acumen Pharmaceuticals and SSMTF positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acumen Pharmaceuticals position performs unexpectedly, SSMTF can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SSMTF will offset losses from the drop in SSMTF's long position.Acumen Pharmaceuticals vs. Terns Pharmaceuticals | Acumen Pharmaceuticals vs. X4 Pharmaceuticals | Acumen Pharmaceuticals vs. Day One Biopharmaceuticals | Acumen Pharmaceuticals vs. Hookipa Pharma |
SSMTF vs. Keurig Dr Pepper | SSMTF vs. SNDL Inc | SSMTF vs. Monster Beverage Corp | SSMTF vs. Willamette Valley Vineyards |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Complementary Tools
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Fundamental Analysis View fundamental data based on most recent published financial statements |